Cargando…
The natural anti-tumor compound Celastrol targets a Myb-C/EBPβ-p300 transcriptional module implicated in myeloid gene expression
Myb is a key regulator of hematopoietic progenitor cell proliferation and differentiation and has emerged as a potential target for the treatment of acute leukemia. Using a myeloid cell line with a stably integrated Myb-inducible reporter gene as a screening tool we have previously identified Celast...
Autores principales: | Coulibaly, Anna, Haas, Astrid, Steinmann, Simone, Jakobs, Anke, Schmidt, Thomas J., Klempnauer, Karl-Heinz |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5796697/ https://www.ncbi.nlm.nih.gov/pubmed/29394256 http://dx.doi.org/10.1371/journal.pone.0190934 |
Ejemplares similares
-
Natural Products with Antitumor Potential Targeting the MYB-C/EBPβ-p300 Transcription Module
por: Schmidt, Thomas J., et al.
Publicado: (2022) -
C/EBPβ is a MYB- and p300-cooperating pro-leukemogenic factor and promising drug target in acute myeloid leukemia
por: Yusenko, Maria V., et al.
Publicado: (2021) -
C/EBPβ cooperates with MYB to maintain the oncogenic program of AML cells
por: Klempnauer, Karl-Heinz
Publicado: (2023) -
A novel cell-based screening assay for small-molecule MYB inhibitors identifies podophyllotoxins teniposide and etoposide as inhibitors of MYB activity
por: Yusenko, Maria, et al.
Publicado: (2018) -
Src-Family Protein Kinase Inhibitors Suppress MYB Activity in a p300-Dependent Manner
por: Biyanee, Abhiruchi, et al.
Publicado: (2022)